CDNA

Caredx Stock Analysis

AI Rating

Neutral
  • Quality3/10
  • Growth 8/10
  • Value 2/10
Caredx sales and earnings growth
CDNA Growth
Good
  • Revenue Y/Y 13.79%
  • EPS Y/Y -140.00%
  • FCF Y/Y 14.43%
Caredx gross and profit margin trends
CDNA Profitability
Neutral
  • Gross margin 67.60%
  • EPS margin -5.60%
  • ROIC 5Y -25.02%
Caredx net debt vs free cash flow
CDNA Risk
Great
  • Debt / Equity 0.1
  • Debt / FCF 0.0
  • Interest coverage -3.3

Caredx stock volatility is in-line with the overall market. We give it a Great risk rating.

More Diagnostics & Research stocks ↗